Page 11 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India urges foreign governments to ease travel restrictions for Indians

India urges foreign governments to ease travel restrictions for Indians
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew delhiRajya sabhaArindam bagchiAntony blinkenBharat biotechEuropean unionAffairsv muraleedharanSerum institute of indiaWorld health organisationExternal affairsv muraleedharanGlobal indian students portalBharat biotech limitedPune based serum instituteState antony blinken

We know the difficulty India faced in vaccine exports: Bangladesh

We know the difficulty India faced in vaccine exports: Bangladesh
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Toshkent shahriVikram doraiswamiAsia centralSerum institute of indiaPune based serum instituteSouth asia centralஆசியா மையசீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்தெற்கு ஆசியா மைய

SII to start producing Sputnik jabs in September | India News

NEW DELHI: In what could bolster the supply of Russia’s Sputnik V in the country, Pune-based Serum Institute of India (SII) will commence its production in September under a technology transfer initiated with Russia’s sovereign wealth fund, Russian Direct Investment Fund. The companies intend to produce over 300 million doses of Sputnik V in India per year. The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September and be commercially available thereafter. In June, the company received regulatory approval to manufacture the Covid-19 vaccine, developed by Russia’s Gamaleya Institute and backed by RDIF.

Serum institute of indiaRussia gamaleya instituteRussian direct investment fundPune based serum instituteRussian direct investmentGamaleya instituteசீரம் நிறுவனம் ஆஃப் இந்தியாரஷ்ய நேரடி முதலீடு நிதிபுனே அடிப்படையிலானது சீரம் நிறுவனம்ரஷ்ய நேரடி முதலீடு

sputnik v vaccine: Serum Institute to begin Sputnik V manufacturing from September

Synopsis With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the vaccine globally, said in a statement. Agencies Representative image As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the vaccine. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the vaccine globally, said in a statement. RDIF had earlier reached agreements with a number of pharmaceutical companies in India (Gland Pharma, Hetero Biopharma,

Adar poonawallaStelis biopharmaGamaleya centerSerum institute of indiaRussian direct investment fundPune based serum instituteDrug controller generalGland pharmaHetero biopharmaVirchow biotechஅடார் பூனாவல்லசீரம் நிறுவனம் ஆஃப் இந்தியாரஷ்ய நேரடி முதலீடு நிதிபுனே அடிப்படையிலானது சீரம் நிறுவனம்மருந்து கட்டுப்படுத்தி ஜநரல்சுரப்பி பார்மா

Coronavirus: India reports 38,792 new infections, 624 fatalities in the last 24 hours

Coronavirus: India reports 38,792 new infections, 624 fatalities in the last 24 hours
scroll.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scroll.in Daily Mail and Mail on Sunday newspapers.

New south walesAndhra pradeshPinarayi vijayanNoah seelamJohns hopkins universityUnion ministry of healthSerum institute of indiaRussian direct investment fundUnion ministryPune based serum instituteSerum instituteChief minister pinarayi vijayanNew indianJohns hopkinsபுதியது தெற்கு வேல்ஸ்ஆந்திரா பிரதேஷ்